Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • JULY 2021 Issue has been successfully launched on 1 July 2021.



Pallavi K. N. and Anil Raj D.*


Background: Hypertensive disorders complicate 5 to 10 percent of all pregnancies and together they are one member of the deadly triad—along with haemorrhage and infection—that contributes greatly to maternal morbidity and mortality. Prevention of any disease process requires a meticulous knowledge of its etiology and pathogenesis. Prediction, prevention, timely diagnosis, early management and providing optimal health care helps to reduce majority of the adverse outcome. Aim: To study Maternal & Fetal outcome in Hypertensive disorders of pregnancy. Materials and Methods: This study was a prospective observational study of total 224 patients with Hypertensive disorders of Pregnancy attending the Little Flower Hospital Angamaly, Kerala in the time period of 2 years. Antenatal women at any gestational age satisfying inclusion and exclusion criteria were included in the study. Consent for the study taken after explaining the need for the study. Statistical analysis was done by SPSS software using Mean, Standard deviation, percentage of various parameters, chi-square test to calculate the P value. Observation and Results: 224 patients were included in the study. Primigravida were 58.92%. Age group of 20-29 (69.19%) with mean age of 26.76 ± 4.26 (Yrs). 72.77% of women had normal BMI, 21.43% had overweight, and 5.36% were obese. 56.2% of women were diagnosed with Gestational hypertension, 16.5% mild Preeclampsia, 19.1% Severe Preeclampsia, 2.7% Eclampsia and 5.4% Chronic hypertension. 59.3% of cases underwent caesarean section and 40.6% delivered vaginally. There was 32.6% total Preterm deliveries & with a statistically significant number in Severe Preeclampsia & Eclampsia (57.5%). Antenatal maternal & fetal complications include abruption placenta (3.57%), FGR (14.3%), IUD (1.34%), HELLP (1.7%), Preterm labour (4.9%), PPROM (6.2%), Oligohydramnios (8%), ARF (0.4%). Postnatal maternal complications include Eclampsia (1.3%), HELLP (0.4%), ARF (0.4%), DIC (1.33%), PPH (3.57%) with no maternal mortality. Neonatal complications include LBW (25.45%), NICU admission (23.7%), Still birth (1.8%), Birth Asphyxia (0.4%), Respiratory Distress (3.12%), Meconium Aspiration (3.12%), & Neonatal death (0.4%). Conclusion: To conclude, though hypertensive disorders in pregnancy is a non-preventable disease, when proper guidelines are followed during regular antenatal check-up, early diagnosis &tertiary referral in needed cases, we can definitely reduce the severity of the disease, & reduce maternal/fetal morbidity and mortality. Complications are unpredictable but early recognition of complications and timely intervention helps to reduce the severe maternal/neonatal morbidity and mortality.

Keywords: .

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More